Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.33% | 38.60 | 0.9% | $1295.75m | |
| JNJ | Johnson & Johnson | 0.32% | 146.29 | 0.7% | $908.06m | |
| MRK | Merck & Co., Inc. | 0.95% | 81.00 | 0.7% | $632.64m | |
| AZN | AstraZeneca Plc | 1.22% | 56.45 | 1.2% | $603.18m | |
| ABBV | AbbVie, Inc. | 0.21% | 95.10 | 1.9% | $602.87m | |
| BMY | Bristol-Myers Squibb Co. | 0.43% | 58.90 | 1.0% | $568.24m | |
| LLY | Eli Lilly & Co. | 1.84% | 153.00 | 1.1% | $430.99m | |
| GSK | GlaxoSmithKline Plc | 1.31% | 40.85 | 0.2% | $135.54m | |
| NVS | Novartis AG | 1.81% | 83.62 | 0.2% | $131.25m | |
| OPK | OPKO Health, Inc. | 3.11% | 5.31 | 12.2% | $129.65m | |
| MIST | Milestone Pharmaceuticals, Inc. | -0.12% | 8.69 | 0.0% | $122.63m | |
| RGEN | Repligen Corp. | -0.23% | 150.91 | 7.1% | $69.52m | |
| NVO | Novo Nordisk A/S | -0.03% | 65.30 | 0.1% | $64.50m | |
| PRNB | Principia Biopharma, Inc. | 0.13% | 83.60 | 0.0% | $56.89m | |
| IMRN | Immuron Ltd. | -0.10% | 10.00 | 0.0% | $49.87m |
Company Profile
Milestone Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. The firm designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada.